Skip to main content
. 2022 Jun 16;38(Suppl 1):55–61. doi: 10.15605/jafes.037.S5

Table 3.

Prevalence rates of co-morbidities among study subjects

Disease Frequency p-value
Cases Controls
Hypertension 34.00% 10.00% 0.003
Ischemic heart disease 14.00% 0.00% ˂0.001
Renal failure 5.00% 0.00% ˂0.001
Retinopathy 61.00% 0.00% ˂0.001
Hypercholesterolemia 6.00% 3.01% 0.005
Hepatitis C virus 1.00% 0.00% ˂0.001
Hepatitis B virus 0.00% 0.00% ˂0.001